Pricing Log in Create free account

Cytosorbents Corporation (CTSO) vs HeartSciences Inc. (HSCS)

Cytosorbents Corporation and HeartSciences Inc. are both Medical Devices companies. Cytosorbents Corporation and HeartSciences Inc. are of similar size ($14.5M and $13.3M). HeartSciences Inc. grew revenue faster over the last twelve months: 131.9% against 3.07%. Cytosorbents Corporation has the higher net margin (−48.9% vs −48,621.8%) and the lower return on invested capital (−66.9% vs 0.00%). Across the 17 metrics below, Cytosorbents Corporation leads on 14 and HeartSciences Inc. on 3.

Valuation

Metric CTSO HSCS Medical Devices median
P/E n/m n/m 24.94
P/S 0.40 488.61 2.66
P/B n/m n/m 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales 0.75 519.02 2.76
Earnings yield (122.11%) (114.59%) (12.66%)
Free cash flow yield (63.17%) (69.02%) (7.18%)

Profitability

Metric CTSO HSCS Medical Devices median
Gross margin 71.61% 18.01% 57.76%
Operating margin (34.74%) (44,918.48%) (14.84%)
Net margin (48.94%) (48,621.80%) (14.45%)
Free cash flow margin (25.32%) (33,725.12%) (5.70%)
Return on equity (336.17%) (1,854.69%) (10.56%)
Return on assets (42.38%) (201.67%) (17.26%)
Return on invested capital (66.90%) 0.00% (5.22%)

Growth

Metric CTSO HSCS Medical Devices median
Revenue growth (TTM) 3.07% 131.87% 10.41%
EPS growth (last fiscal year) 65.79% 62.74% 28.17%
Revenue growth, 5-year CAGR (2.00%) (30.01%) 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTSO HSCS Medical Devices median
Debt to equity (22.96) 0.00 0.04
Current ratio 0.66 0.14 2.67
Net debt to EBITDA (0.85) 0.21 0.54

Dividend

Metric CTSO HSCS Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric CTSO HSCS Medical Devices median
Market cap 14.50m 13.26m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack